# Docusate Sodium and Sennosides

NDC: 87717-502
Generic name: Docusate Sodium and Sennosides
Labeler / Manufacturer: Morepen Bio Inc
Product type: HUMAN OTC DRUG
Marketing category: OTC monograph drug
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260710

FDA application: M007

## Active ingredients

- DOCUSATE SODIUM: 50 mg/1
- SENNOSIDES: 8.6 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87717-502"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87717-502
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=562d1b9a-09d8-92fc-e063-6394a90a1993